Bladder Cancer in Adults: Screening

  1. Randomized, controlled trials or well-designed case-control studies to evaluate clinical outcomes in screened versus unscreened populations.
  2. Harms of screening and treatment.
  3. Cohort studies of the natural history of early-stage, untreated bladder cancer to elucidate potential overdiagnosis and overtreatment associated with screen-detected bladder cancer.
  4. Diagnostic accuracy of urine screening tests in representative populations.
  5. Effect of screening on bladder cancer incidence, tumor characteristics, and subsequent treatments.
  6. Comparisons of the effects of using less-toxic treatments earlier and more frequently to prevent progression, versus using treatments with greater toxicity.

The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for bladder cancer in asymptomatic adults.

Bladder Cancer in Adults: Screening Read full statement 1